The study uncovered the usual gastrointestinal issues linked to GLP-1 drugs, like abdominal pain, nausea and vomiting, as well as less well-known conditions, including stomach paralysis and diverticulitis, where bulging pouches of the large intestine become inflamed
It also notes severity tracks with baseline BMI and the speed of loss rather than medication dose alone, and that some people lose weight quickly with no cycle change at all
For target weight reduction (Table 2 and Supplementary Material Fig
endocrine disease (Type 1 diabetes, hyperthyroidism, hypothyroidism)
Understanding Anthem and GLP-1 medications GLP-1 receptor agonists have transformed the weight loss landscape
If tolerated well, the dose may go up every four weeks to 7.5 mg, then 10 mg, and possibly up to 15 mg per week